Sisram Medical, parent company of Alma Lasers, reported solid interim results for the first half of 2026, with growth driven by strength in Asia-Pacific markets. The company's laser and energy-device portfolio—including the Harmony platform for multi-modality treatments and Soprano ICE diode laser systems—continues to gain traction in high-growth regions.
Business & M&A
Sisram Medical Posts Solid H1 2026 Results
The Alma Lasers parent company delivers interim earnings amid APAC growth.
Sisram Medical delivers solid H1 2026 results on APAC growth.
The APAC expansion underscores a broader shift in device capital deployment toward emerging markets and the growing appetite for integrated platforms that consolidate multiple modalities (RF, laser, ultrasound) into single systems. For U.S. practice owners, Sisram's momentum abroad signals competitive pressure to upgrade aging single-indication devices and invest in versatile platforms that can address multiple treatment categories—skin resurfacing, hair removal, body sculpting—from one manufacturer.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.